No products in the cart.
Noctura 400 is being used to treat patients with
A patients Diabetic Eye Grading should be on record as supplied from Diabetic Eye Screening or the Hospital Eye Service.
Noctura 400 is a sleep mask which emits green light treatment of a specific wavelength into the eyes during sleep. Worn every night, the light prevents hypoxia within the eye, therefore preventing the development of problematic blood vessels which lead to Diabetic Retinopathy.
Each Noctura 400 mask lasts for 84 days. The timeframe has been designed to allow the clinical review of patients approximately every 3 months, often in line with national diabetic eye screening.
Mask wear is recorded by capacitive cheek sensors, and patients mask wear compliance can therefore be monitored.
Noctura 400 is a non-invasive treatment that can be used alone, or as an adjunct to conventional treatment - this is explained well by Mr Meyer-Bothling, a Consultant Ophthalmologist at Ashford St Peters Trust, in the below video.
When a patient is prescribed Noctura 400, it isn't just the product - there is a full support team behind them. The Noctura Advisory line is contactable every day from 9-5 with real Noctura 400 experts manning the phones.
There are plenty of online resources that they will be directed to in the first weeks of use. Below is our training video, especially for helping new customers get used to the mask.
2. Meyer-Bothling U, Meyer-Bothling O, Pinney M, A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year , Journal of Ophthalmology, 2021.
3. Sahni JN, Czanner, Gutu T et al. Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease. , Eye (Lond). 2017; 31: 97-106
4. Arden GB, Jyothi S, Hogg CH et al. Regression of early diabetic macular oedema is associated with prevention of dark adaption. , Eye 2011;25(12):1546-54.
5. Kuchynyka P, Grierson I, Veith D et al.Patients with diabetic eye disease using a potentially therapeutic mask. Do sufficient patients wear the mask and for how long?. , Adv Ophthalmol Vis Syst. 2017; 7: 00253
6. Arden GB, Gündüz MK, Kurtenbach A, Völker M, Zrenner E, Gündüz SB et al. Preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. , Eye 2010; 24: 1149–1155.
7. Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144) , 2018 - ISBN: 978-1-4731-2906-1.
8. ‘If a patient does not take a treatment, they cannot derive any benefit’ – Cleopatra Rebuttal
